Clinical Review

Dopamine Antagonist Prescribing Practices in Patients With Parkinson Disease

Author and Disclosure Information

This study examines clinician prescribing habits at 3 VAMCs to see whether a change in the electronic medical record at 1 VAMC leads to a change in prescribing patterns of dopamine antagonists in patients with Parkinson disease compared with the other 2 centers.

Psychosis and nausea are common problems in patients with Parkinson disease (PD) and are often treated with dopamine antagonists, medications that can worsen parkinsonism. In 2 surveys of clinic patients with PD, 24.4% complained of nausea at least once in the month before the clinic visit, and 39.8% experienced hallucinations in the 3 months before the visit.(1,2)


 

Recommended Reading

Korean Veterans Affected by New Benefits Policy
Federal Practitioner
Health Literacy, Clear Communication Prompting, and Clinicians' Self-Reported Responses
Federal Practitioner
When Good Intentions Fall Through
Federal Practitioner
Cognitive Screening in 2 Minutes
Federal Practitioner
Cognitive Screening in 2 Minutes
Federal Practitioner
Study of Antidepression Implant Underway
Federal Practitioner
The VHA's National Pain Management Strategy: Implementing the Stepped Care Model
Federal Practitioner
Insulin Spray May Help Combat Alzheimer Disease
Federal Practitioner
Reaching Out to Caregivers of Veterans With Dementia
Federal Practitioner
Anti-Alzheimer Disease Drugs in Real Life
Federal Practitioner